Interview of Jessica Mitchell, RN, CNP, MPH


Interview of Jessica Mitchell, RN, CNP, MPH
In this interview originally conducted for our Oncology Nursing Update series, nurse practitioner Jessica Mitchell gave her perspective on caring for patients with metastatic colorectal cancer, including the particularly difficult situation of patients with incurable disease and minor children.

To hear more of this program or to access addition audio and video programs designed for nurses,
please visit ResearchToPractice.com/Nurses.

 

Jessica Mitchell, RN, CNP, MPH
Certified Nurse Practitioner
GI Medical Oncology
Mayo Clinic
Rochester, Minnesota

Track 1: Case discussion: A 38-year-old single mother of minor children who experiences a second mCRC progression on bevacizumab-based therapy receives aflibercept/FOLFIRI
Track 2: Use of alternative and complementary therapies for patients with mCRC
Track 3: Communicating expected risks and side effects of chemotherapy to patients
Track 4: Counseling patients with metastatic disease about discussing cancer and its treatment with their children
Track 5: Response to and tolerability of FOLFIRI/bevacizumab in mCRC
Track 6: Support system for patients coping with mCRC and its treatment
Track 7: Management of bevacizumab-associated hypertension
Track 8: Continuation of anti-angiogenic therapy after disease progression on first-line therapy for mCRC
Track 9: Counseling patients about the potential side effects of aflibercept
Track 10: Consideration of regorafenib as later-line therapy for mCRC
Track 11: Case discussion: A 53-year-old patient with KRAS wild-type mCRC whose disease progresses through multiple lines of therapy receives regorafenib
Track 12: Prevention and management of regorafenib-related hand-foot syndrome
Track 13: Clinical experience with and tolerability of regorafenib for mCRC
Track 14: Importance of family support and religion in coping with a terminal illness
Track 15: Managing dermatologic toxicity in patients receiving cetuximab therapy